BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32714746)

  • 1. Covalent Inhibitors Allosterically Block the Activation of Rho Family Proteins and Suppress Cancer Cell Invasion.
    Sun Z; Zhang H; Zhang Y; Liao L; Zhou W; Zhang F; Lian F; Huang J; Xu P; Zhang R; Lu W; Zhu M; Tao H; Yang F; Ding H; Chen S; Yue L; Zhou B; Zhang N; Tan M; Jiang H; Chen K; Liu B; Liu C; Dang Y; Luo C
    Adv Sci (Weinh); 2020 Jul; 7(14):2000098. PubMed ID: 32714746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
    Boissier P; Huynh-Do U
    Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent Fragment Inhibits RhoA Activation by Guanine Exchange Factors.
    Hussain MS; Liu D; Alilain WJ; Meroueh SO
    ACS Chem Neurosci; 2023 Jul; 14(14):2509-2516. PubMed ID: 37382289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors.
    Shang X; Marchioni F; Evelyn CR; Sipes N; Zhou X; Seibel W; Wortman M; Zheng Y
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3155-60. PubMed ID: 23382194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residues of the Rho family GTPases Rho and Cdc42 that specify sensitivity to Dbl-like guanine nucleotide exchange factors.
    Li R; Zheng Y
    J Biol Chem; 1997 Feb; 272(8):4671-9. PubMed ID: 9030518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
    Heo J; Thapar R; Campbell SL
    Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation.
    Wei L; Imanaka-Yoshida K; Wang L; Zhan S; Schneider MD; DeMayo FJ; Schwartz RJ
    Development; 2002 Apr; 129(7):1705-14. PubMed ID: 11923206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutationally activated Rho GTPases in cancer.
    Alan JK; Lundquist EA
    Small GTPases; 2013; 4(3):159-63. PubMed ID: 24088985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant.
    Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y
    J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho GTPase regulatory proteins in podocytes.
    Matsuda J; Asano-Matsuda K; Kitzler TM; Takano T
    Kidney Int; 2021 Feb; 99(2):336-345. PubMed ID: 33122025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of anesthetics with the Rho GTPase regulator Rho GDP dissociation inhibitor.
    Ho C; Shanmugasundararaj S; Miller KW; Malinowski SA; Cook AC; Slater SJ
    Biochemistry; 2008 Sep; 47(36):9540-52. PubMed ID: 18702520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive regulation of Rho GTPase activity by RhoGDIs as a result of their direct interaction with GAPs.
    Ota T; Maeda M; Okamoto M; Tatsuka M
    BMC Syst Biol; 2015 Jan; 9():3. PubMed ID: 25628036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Mg2+ cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins.
    Zhang B; Zhang Y; Wang Z; Zheng Y
    J Biol Chem; 2000 Aug; 275(33):25299-307. PubMed ID: 10843989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Rho GEF and RhoA Activation by Pull-Down Assays.
    Sajib MS; Zahra FT; Akwii RG; Mikelis CM
    Methods Mol Biol; 2021; 2193():97-109. PubMed ID: 32808262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDIs: central regulatory molecules in Rho GTPase activation.
    DerMardirossian C; Bokoch GM
    Trends Cell Biol; 2005 Jul; 15(7):356-63. PubMed ID: 15921909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-specific Guanine nucleotide exchange factors (Rho-GEFs) inhibition affects macrophage phenotype and disrupts Golgi complex.
    Chen W; Zhao Y; Li XC; Kubiak JZ; Ghobrial RM; Kloc M
    Int J Biochem Cell Biol; 2017 Dec; 93():12-24. PubMed ID: 29061365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical overview of Rho GTPases.
    Ridley AJ
    Methods Mol Biol; 2012; 827():3-12. PubMed ID: 22144264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility.
    Friesland A; Zhao Y; Chen YH; Wang L; Zhou H; Lu Q
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1261-6. PubMed ID: 23284167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho GTPases: promising cellular targets for novel anticancer drugs.
    Fritz G; Kaina B
    Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myosin II directly binds and inhibits Dbl family guanine nucleotide exchange factors: a possible link to Rho family GTPases.
    Lee CS; Choi CK; Shin EY; Schwartz MA; Kim EG
    J Cell Biol; 2010 Aug; 190(4):663-74. PubMed ID: 20713598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.